Literature DB >> 6510453

The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.

J C Mucklow, S Kuhn.   

Abstract

The effects of penbutolol (40 mg), atenolol (100 mg) and sustained-release metoprolol (metoprolol SA) (200 mg) upon heart rate (HR) and blood pressure (BP) at rest and during bicycle ergometer exercise, have been compared in 12 healthy young men using a double-blind crossover design. Measurements of each drug's effect were made before and at 3, 10 and 24 h after a single dose, and again at 24 h after the last of seven consecutive daily doses. Resting HR and systolic BP were reduced to an equivalent extent by all three drugs. During the third minute of exercise, the effects of penbutolol and atenolol upon HR and systolic BP were consistently similar and greater than those of metoprolol SA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6510453     DOI: 10.1007/bf00542158

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.

Authors:  J F Giudicelli; C Richer; M Chauvin; N Idrissi; A Berdeaux
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

2.  Intrinsic heart rate on exercise and the measurement of beta-adrenoceptor blockade.

Authors:  S G Carruthers; R G Shanks; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

3.  Determination of penbutolol and its hydroxylated metabolite in biological fluids by reversed-phase high-performance liquid chromatography.

Authors:  N Bernard; G Cuisinaud; J Sassard
Journal:  J Chromatogr       Date:  1982-03-12

Review 4.  Clinical pharmacokinetics of metoprolol.

Authors:  C G Regårdh; G Johnsson
Journal:  Clin Pharmacokinet       Date:  1980 Nov-Dec       Impact factor: 6.447

5.  Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA).

Authors:  D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

6.  Atenolol reduces blood pressure and FEV in normal subjects.

Authors:  R W Fuller; P J Vallance
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

7.  Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

8.  High-performance liquid chromatographic measurement of atenolol: methodology and clinical applications.

Authors:  R K Bhamra; K J Thorley; J A Vale; D W Holt
Journal:  Ther Drug Monit       Date:  1983       Impact factor: 3.681

9.  Duration of action of beta blockers.

Authors:  S R Johansson; M McCall; C Wilhelmsson; J A Vedin
Journal:  Clin Pharmacol Ther       Date:  1980-05       Impact factor: 6.875

10.  Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.

Authors:  S Freestone; J H Silas; M S Lennard; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.